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Several genetic systems have been reported that regulate the antibody re- 
sponse to H-2D  ~ alloantigens in mice (1-5).  Some of the described genes are 
linked to H-2  (2, 3) whereas other genes are located outside the H-2 complex (1, 
4, 5). 
A detailed investigation of the immunological phenomena that are regulated 
by one of the genetic systems located outside H-2 has shown that some mice of 
the C57BL/10 series respond with only IgM alloantibodies to congenic immuni- 
zations with H-2D  b different cells (4-6).  Most experiments have been performed 
with B10.A(5R) mice (5R)  1 immunized with C57BL/10 (B10) spleen cells. Even 
repeated injections with B10 cells yield only IgM antibodies. On the other hand, 
immunization with A.BY spleen cells,  which carry other foreign cell surface 
antigens in addition to H-2D  b, leads to antibody production of  the IgG type (4). 
The experiments performed here were designed to investigate the effect of 
preimmunization with B10 cells on the response to subsequent immunization 
with A.BY cells. The results indicate that preimmunization with congenic cells 
can lead to inhibition of the normally occurring IgG response to noncongenic 
cells. 
Materials and Methods 
Mice and Immunizations.  All animals used in the experiments reported here were from our 
own colonies of inbred mouse strains. B10.A(5R) mice (2-6-mo-old) were immunized with normal 
spleen cells of strains B10, A.BY, and A. TheH-2 haplotypes of these strains are shown in Table I. 
5R belongs to the series of congenic strains of C57BL/10 origin (7); its H-2 haplotype (H-2 "~) (8) is 
derived from a crossover between H-2  ~ and H-2  ° occurring between I-B and I-C (9). B10 and A.BY 
mice both carry the H-2D  ° haplotype, B10 on the same background as 5R, A.BY carrying the extra 
H-2 genome of the unrelated strain A. Since 5R and B10 are congenic strains which differ at only 
part of the H-2 complex, immunizations of 5R mice with B10 cells are directed solely against gene 
products governed by the I-C  °, S b, or D ° regions of the H-2 complex. Immunizations with A.BY 
cells  are  directed  against  the  same  products  and,  in  addition,  against  non-H-2  cell  surface 
antigens, whereas immunizations with cells of strain A are directed against H-2K  k, I-A k, and/-B  ~" 
plus cell surface antigens coded for by genes outside H-2. 
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TABLE  I 
H-2 Haplotype of All Mouse Strains  Used 
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H-2 Complex  Non-H-2 
Haplotype  K  I-A  I-B  I-C  S  D  background 
Responding strain 
B10.A(SR)  H-2 ~  b  b  b  I  d  d  d  C57BL/10 
Immunizing cells 
B10  H-2  b  b  b  b  b  b  b  C57BL/10 
A.BY  H-2 b  b  b  b  b  b  b  A 
A  H-2 ~  k  k  k  [  d  d  d  A 
Target cells in cytotoxic- 
ity tests 
B10.HTG  H-2 °  d  d  d  d  d  I  b  C57BL/10 
B10.BR  H-2 k  k  k  k  k  k  k  C57BL/10 
Vertical bars indicate site of crossover. 
5R mice received a  first inoculation of 0.5  ×  106 normal spleen cells injected subcutaneously; 2 
wk later 5  ×  10  ~ cells were injected intraperitoneally, and the immunization was continued with 
biweekly intraperitoneal injections of 10 ×  10  ~ cells. In consecutive immunizations with cells from 
different strains, 5R mice were first injected with B10 or A.BY cells, and then at various intervals 
a new immunization was begun with either A.BY or A, starting again with 0.5 ×  10  ~ cells injected 
subcutaneously. 
The immunized mice were bled from the retroorbital plexus 7 days after the fourth and fifth 
injection of the final immunization and were  exsanguinated by heart puncture after the sixth 
immunization. 
All antisera were  stored  at  -70°C  until tested.  As target cells in the complement-mediated 
cytotoxicity test lymph node cells from strain B10.HTG were used to test for anti-H-2D  b antibodies 
and lymph node cells from B10.BR mice were chosen to test for antibodies againstH-2K  A (Table I). 
Complement-Mediated Cytotoxicity Test.  The complement-mediated cytotoxicity test for anti- 
body activity was performed on ~lCr-labeled lymph node cells as previously described (4) with the 
following modification to allow for greater sensitivity and the use of 2-mercaptoethanol (2-Me) to 
test for 2-Me-sensitive and 2-Me-resistant antibodies. Instead of a one-step cytotoxicity assay with 
an incubation time of 1 h at room temperature, a two-step test was used in which the labeled target 
cells were incubated with antiserum in the cold,  centrifuged,  and then incubated at 37°C  with 
guinea pig complement. Disulfide bond reduction of the H-2 antibodies with 2-Me was carried out 
by incubating equal volumes of serum and 0.1 M 2-Me for 30 min at 37°C as described by Klein et 
al. (10), assuming that 2-Me-sensitive antibodies are of IgM type whereas 2-Me-resistant antibod- 
ies are of IgG type. 
Results 
We have previously described that B10.A(5R) mice produce only anti-H-2D b 
antibodies of  IgM type (2-Me-sensitive) when immunized with congenic B10 cells 
(4,  6).  On the other hand they are capable of mounting an anti-H-2D  b  IgG 
response  if the  antigen is presented  on a  cell that carries other foreign cell 
surface antigens in addition to H-2D b as is the case with A.BY cells (Fig. 1). 
We have now investigated the effect of preimmunization of 5R mice with B10 
cells on the IgG response to a  subsequent immunization with A.BY cells.  5R 
mice were injected once or twice with B10 cells or with A.BY cells as a control. 
Then a new immunization was started with 0.5  ×  106 A.BY cells given subcuta- 656  INHIBITION  OF  THE  IgG  RESPONSE  TO  H-2D  ~ 
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FIG.  1.  Antibody levels as measured by a  complement-mediated slCr release cytotoxicity 
assay. Titration on B10.HTG target cells of sera collected 7 days after the sixth injection of 
5R mice with A.BY (m--m, [3- -  -[:]) or B10 (0--0,  ©- -  -©) normal spleen cells. Straight 
lines: sera not treated  with 2-Me. Dotted lines: sera aider 2-Me treatment. 
neously. The results are shown in Fig. 2. When the second immunization with 
A.BY cells was begun  7 days after one  injection of B10  cells,  the anti-A.BY 
response was of  IgG type (panel A). No influence of  the B10 injection on the anti- 
A.BY response could be seen. On the other hand if  the subsequent immunization 
with A.BY cells was given after 5R mice had received two injections of  B10 cells, 
the mice were unable to mount an IgG response toH-2D b on A.BY; even after six 
injections with A.BY cells only IgM antibodies could be  detected (panel  C). 
Identical results were obtained if  5R mice were first injected with B10 cells three 
times. 
Two controls were performed: Immunization with A.BY cells was begun 21 
days after one  injection of B10  cells to  test whether the time after the first 
injection was critical (7 days after the second injection corresponds to 21 days 
after the first injection) or if the second injection with B10 cells was responsible 
for the failure to mount an IgG response to the immunization with A.BY cells. 
As shown in panel B of Fig. 2, the critical factor is not the time after the first 
injection but the second injection with B10 cells. 
Panel D illustrates a control in which a second immunization with A.BY cells 
was started after two injections with A.BY cells. No effect on the IgG response is 
seen. 
To test whether the inhibition of the IgG response was specific for H-2D ~ and 
did not apply to another  H-2 antigen, 5R mice were injected twice with B10 cells 
and 7 days later an immunization with spleen cells of strain A was started. As 
can  be  seen  in  Fig.  3,  5R mice  did  produce  IgG antibodies  to H-2K ~  when 
immunized with A cells indicating that failure to produce IgG antibodies to H- 
2D b  after previous injections with B10  cells is specific for the H-2D b  antigen 
carried on the congenic B10 cell. DOROTHEE 
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FIG.  2.  Antibody levels as measured  by a  complement-mediated  ~lCr release cytotoxicity 
assay. Titration  on B10.HTG target cells of sera collected  7  days after the fifth  and  sixth 
injection  of 5R mice with A.BY normal  spleen cells.  Straight  lines: sera not treated with 2- 
Me. Dotted lines:  sera after 2-Me treatment. (A) 5R anti-B10 1-7 anti-A.BY: 7 days after a 
first injection  with B10 cells an immunization with A.BY cells was begun. (B) 5R anti-B10 
1-21  anti-A.BY: 21 days after a  first injection  with B10 cells an immunization with A.BY 
cells was begun. (C) 5R anti-B10 2-7 anti-A.BY: 7 days after the second  injection  with B10 
cells an immunization  with A.BY cells was begun. (D) 5R anti-A.BY 2-7 anti-A.BY: 7 days 
after  the  second  injection  with A.BY  cells  another  immunization  with A.BY  cells was 
begun. 
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Discussion 
In previous publications we have described that B10.A(5R) mice secrete only 
IgM type antibodies to H-2D b if immunized with congenic  B10 cells,  whereas 
they are capable of mounting an IgG response to the same antigen if this antigen 
is presented on cells that carry additional foreign cell surface antigens, e.g. EL4 
leukemia cells,  or A.BY or BALB.B  spleen cells  (4, 6,  11). 
The experiments reported here indicate that preimmunization of 5R mice with 
congenic  B10 cells  leads to failure  to produce IgG antibodies in a  subsequent 
immunization with A.BY cells, but does so only if5R mice are injected with B10 
cells twice.  One injection of B10 cells does not have any effect. The lack of IgG 
response was shown to be specific for H-2D b since it did not apply to a  subse- 
quent immunization against H-2K k. 
It has been described by Klein et al.  (10) that one injection with H-2 different 
cells  leads  to  a  thymus-independent  alloantibody  response  of IgM type  only. 658  INHIBITION  OF  THE  IgG  RESPONSE  TO  H-2D  b 
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FIG.  3.  Antibody levels as measured by a complement-mediated ~Cr release cytotoxicity 
assay. 5R anti-B10 2-7 anti-A: 5R mice were first injected with B10 cells two times, 7 days 
after the second injection with B10  cells an immunization with normal spleen cells from 
strain A was begun. Titration on B10.BR target cells of sera collected 7 days after the fifth 
and sixth immunization. Straight lines: sera not treated with 2-Me. Dotted lines: sera aider 
2-Me treatment. 
After a second injection a thymus-dependent IgG response can be detected that 
is abolished if the mice have been thymectomized, irradiated,  and reconstituted 
with bone marrow cells (T-cell deficient "B" mice). 
These results are in agreement with our findings that upon preimmunization 
with B10 cells one injection of congenic cells does not have any effect on the IgG 
response to A.BY cells, whereas after two injections of B10 cells the subsequent 
IgG  response  is  abolished.  It  would  seem that  the  first  encounter  with  H-2 
different cells activates only IgM producing B cells and has no effect on thymus- 
derived lymphocytes; the second injection is necessary to involve the T cells that 
are responsible for the switch from IgM to IgG, and at this second injection, 5R 
mice display a defective response to B10 cells. 
Applying Klein's data (which have been confirmed in part in our laboratory, 
D.  Wernet,  unpublished  observation)  to  our  experiments,  it  seems  that 
B10.A(5R)  mice  behave  like  "B"  mice  in  an  H-2D b  congenic  immunization, 
displaying  a  defect in  T-cell  function  that  renders  them  unable  to  mount  a 
thymus-dependent IgG response under those circumstances. The fact that they 
can produce IgG antibodies  if the  same antigen  is presented  on a  cell which 
carries additional foreign cell surface antigens has led to the following hypothe- 
sis  (4): For 5R mice, H-2D b alloantigens  presented on a  congenic background 
without additional foreign cell surface antigens are analogous to a "hapten" on a 
carrier that has no activating capacity for the helper T cells (a nonimmunogenic 
carrier). This "hapten" elicits a thymus-independent IgM response only, as has 
been demonstrated in other systems with autologous red blood cells as nonim- 
munogenic carriers  (12,  13). For lack of activation of the helper T  cells by the 
nonimmunogenic carrier the switch from the initial IgM antibody production to 
the secondary IgG response does not occur (14). Additional foreign cell surface DOROTHEE  WERNET,  HOLLY  SHAFRAN,  AND  FRANK  LILLY  659 
antigens convert the nonimmunogenic  carrier into an immunogenic  carrier that 
induces activation of T-cell help to elicit an IgG response. Helper activity by 
additional histocempatibility antigens in respect to another T-cell function (cell- 
mediated immunity) has been reported by DiMarco et al.  (15). 
The data reported here indicate that the failure to produce IgG antibodies may 
not be  the  result  of simple lack  of T-cell helper function but  may involve 
tolerance or suppression at the T- or B-cell level. Lack of T-cell help for instance 
may lead to B-cell tolerance to the specific antigen so that the B-cells are unable 
to respond to the specific T-cell signal that is later provided by immunization 
with A.BY cells. B-cell tolerance has been described by Hamilton et al. (16) in a 
hapten carrier system with syngeneic erythrocytes. 
At this moment we favor another possible model: Immunization of 5R mice 
with B10 cells elicits only on IgM response because of lack of carrier-dependent 
T-cell help. Instead ofT-cell help, suppressor T cells are activated that act either 
directly on B cells  (17), rendering them tolerant to subsequent helper T-cell 
signals,  or suppressor T  cells act on helper T  cells (18) suppressing the IgG 
response that would otherwise be initiated. Suppression of the IgG response by 
suppressor T cells has been described in different systems (19, 20). This model 
implies different sets of T cells for helper function and suppressor function, a 
likely notion since Feldmann et al. have shown different Ly antigen phenotypes 
of helper and suppressor T cells induced in vitro (21). 
With slight variation this model would also be consistent with the possibility 
that in normal immunized mice there are helper T cells and suppressor T cells 
present at the same time interacting with each other. The assumption would be 
that once the controlling factor of the helper T cell is lacking, the suppressor T 
cells become dominant over any T-cell help that might normally be induced by a 
second immunization with different cells. 
At this moment there is no experimental evidence as to which model may be 
correct in  the  B10.A(5R)  anti-B10  immunization.  The  lack  of helper  T-cell 
activation in H-2-cengenic immunizations may be a fairly common phenomenon 
in inbred strains of mice (3) and may also apply to the antibody response to other 
cell surface antigens (22) and to tumor specific antigens on syngeneic  tumor cells 
in which case activation of B-cell tolerance or T-cell-mediated suppression may 
strongly influence the outcome of tumor growth. 
Summary 
When B10.A(5R) mice (H-2 i5) are immunized with spleen cells from congenic 
B10 mice (H-2b), they respond to alloantigens of the H-2D  b region by producing 
antibodies of only IgM  type.  In  contrast,  they produce both  IgM  and  IgG 
antibodies when immunized with A.BY cells (H-2 ~) that carry other foreign cell 
surface antigens (non-H-2) in addition to H-2D  ~. Preimmunization of 5R mice 
with two injections of congenic cells leads to an H-2D  ~ specific inhibition of the 
IgG response to a subsequent immunization with A.BY cells. It is concluded that 
congenic B10 cells fail to activate helper T cells which are necessary to induce 
the switch from IgM to IgG production. Instead T- or B-cell tolerance may be 
induced with prohibits the subsequent IgG response to A.BY cells, possibly by 
way of suppressor T cells which may act either on B cells directly or via helper T 
cells. 660  INHIBITION  OF  THE  IgG  RESPONSE  TO  H-2D b 
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